| 001 | 155574 | ||
| 005 | 20240320115511.0 | ||
| 024 | 7 | _ | |a pmc:PMC8563628 |2 pmc |
| 024 | 7 | _ | |a 10.1007/s00415-021-10568-9 |2 doi |
| 024 | 7 | _ | |a pmid:33904966 |2 pmid |
| 024 | 7 | _ | |a 0012-1037 |2 ISSN |
| 024 | 7 | _ | |a 0340-5354 |2 ISSN |
| 024 | 7 | _ | |a 0939-1517 |2 ISSN |
| 024 | 7 | _ | |a 1432-1459 |2 ISSN |
| 024 | 7 | _ | |a 1619-800X |2 ISSN |
| 024 | 7 | _ | |a altmetric:104785111 |2 altmetric |
| 024 | 7 | _ | |a 0367-004x |2 ISSN |
| 024 | 7 | _ | |a 0367-004X |2 ISSN |
| 037 | _ | _ | |a DZNE-2021-00752 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Schmidt, Nele |b 0 |
| 245 | _ | _ | |a Memory enhancement by multidomain group cognitive training in patients with Parkinson's disease and mild cognitive impairment: long-term effects of a multicenter randomized controlled trial. |
| 260 | _ | _ | |a Berlin |c 2021 |b Springer |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1636454870_20945 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a ISSN 1432-1459 not unique: **2 hits**. |
| 520 | _ | _ | |a Meta-analyses indicate positive effects of cognitive training (CT) in patients with Parkinson's disease (PD), however, most previous studies had small sample sizes and did not evaluate long-term follow-up. Therefore, a multicenter randomized controlled, single-blinded trial (Train-ParC study) was conducted to examine CT effects in PD patients with mild cognitive impairment (PD-MCI). Immediately after CT, an enhancement of executive functions was demonstrated. Here, we present the long-term results 6 and 12 months after CT.At baseline, 64 PD-MCI patients were randomized to a multidomain CT group (n = 33) or to a low-intensity physical activity training control group (PT) (n = 31). Both interventions included 90 min training sessions twice a week for 6 weeks. 54 patients completed the 6 months (CT: n = 28, PT: n = 26) and 49 patients the 12 months follow-up assessment (CT: n = 25, PT: n = 24). Primary study outcomes were memory and executive functioning composite scores. Mixed repeated measures ANOVAs, post-hoc t tests and multiple regression analyses were conducted.We found a significant time x group interaction effect for the memory composite score (p = 0.006, η2 = 0.214), but not for the executive composite score (p = 0.967, η2 = 0.002). Post-hoc t tests revealed significant verbal and nonverbal memory improvements from pre-intervention to 6 months, but not to 12 months follow-up assessment in the CT group. No significant predictors were found for predicting memory improvement after CT.This study provides Class 1 evidence that multidomain CT enhances memory functioning in PD-MCI after 6 months but not after 12 months, whereas executive functioning did not change in the long-term.German Clinical Trials Register (ID: DRKS00010186), 21.3.2016 (The study registration is outlined as retrospective due to an administrative delay. The first patient was enrolled three months after the registration process was started. A formal confirmation of this process from the German Clinical Trials Register can be obtained from the authors.). |
| 536 | _ | _ | |a 353 - Clinical and Health Care Research (POF4-353) |0 G:(DE-HGF)POF4-353 |c POF4-353 |f POF IV |x 0 |
| 542 | _ | _ | |i 2021-04-27 |2 Crossref |u https://creativecommons.org/licenses/by/4.0 |
| 542 | _ | _ | |i 2021-04-27 |2 Crossref |u https://creativecommons.org/licenses/by/4.0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |a Cognition |2 Other |
| 650 | _ | 7 | |a Cognitive training |2 Other |
| 650 | _ | 7 | |a Long-term effects |2 Other |
| 650 | _ | 7 | |a Mild cognitive impairment |2 Other |
| 650 | _ | 7 | |a Non-pharmacological intervention |2 Other |
| 650 | _ | 7 | |a Parkinson’s disease |2 Other |
| 650 | _ | 2 | |a Cognition |2 MeSH |
| 650 | _ | 2 | |a Cognition Disorders |2 MeSH |
| 650 | _ | 2 | |a Cognitive Dysfunction: etiology |2 MeSH |
| 650 | _ | 2 | |a Cognitive Dysfunction: therapy |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Neuropsychological Tests |2 MeSH |
| 650 | _ | 2 | |a Parkinson Disease: complications |2 MeSH |
| 650 | _ | 2 | |a Parkinson Disease: therapy |2 MeSH |
| 650 | _ | 2 | |a Retrospective Studies |2 MeSH |
| 700 | 1 | _ | |a Tödt, Inken |b 1 |
| 700 | 1 | _ | |a Berg, Daniela |0 P:(DE-2719)2000059 |b 2 |u dzne |
| 700 | 1 | _ | |a Schlenstedt, Christian |b 3 |
| 700 | 1 | _ | |a Folkerts, Ann-Kristin |b 4 |
| 700 | 1 | _ | |a Ophey, Anja |b 5 |
| 700 | 1 | _ | |a Dimenshteyn, Karina |b 6 |
| 700 | 1 | _ | |a Elben, Saskia |b 7 |
| 700 | 1 | _ | |a Wojtecki, Lars |b 8 |
| 700 | 1 | _ | |a Liepelt-Scarfone, Inga |0 P:(DE-2719)2109499 |b 9 |u dzne |
| 700 | 1 | _ | |a Schulte, Claudia |0 P:(DE-2719)9000366 |b 10 |u dzne |
| 700 | 1 | _ | |a Sulzer, Patricia |0 P:(DE-2719)2811919 |b 11 |u dzne |
| 700 | 1 | _ | |a Eggers, Carsten |b 12 |
| 700 | 1 | _ | |a Kalbe, Elke |b 13 |
| 700 | 1 | _ | |a Witt, Karsten |0 P:(DE-HGF)0 |b 14 |e Corresponding author |
| 773 | 1 | 8 | |a 10.1007/s00415-021-10568-9 |b Springer Science and Business Media LLC |d 2021-04-27 |n 12 |p 4655-4666 |3 journal-article |2 Crossref |t Journal of Neurology |v 268 |y 2021 |x 0340-5354 |
| 773 | _ | _ | |a 10.1007/s00415-021-10568-9 |0 PERI:(DE-600)1421299-7 |n 12 |p 4655-4666 |t Journal of neurology |v 268 |y 2021 |x 0340-5354 |
| 856 | 4 | _ | |u https://link.springer.com/article/10.1007%2Fs00415-021-10568-9 |
| 856 | 4 | _ | |u https://pub.dzne.de/record/155574/files/19590.pdf |y OpenAccess |
| 856 | 4 | _ | |u https://pub.dzne.de/record/155574/files/19590.pdf?subformat=pdfa |x pdfa |y OpenAccess |
| 909 | C | O | |o oai:pub.dzne.de:155574 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 2 |6 P:(DE-2719)2000059 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 9 |6 P:(DE-2719)2109499 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 10 |6 P:(DE-2719)9000366 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 11 |6 P:(DE-2719)2811919 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-353 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 0 |
| 913 | 0 | _ | |a DE-HGF |b Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-345 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Population Studies and Genetics |x 0 |
| 913 | 0 | _ | |a DE-HGF |b Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-344 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 1 |
| 914 | 1 | _ | |y 2021 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-12 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2022-11-12 |
| 915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2022-11-12 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b J NEUROL : 2021 |d 2022-11-12 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-12 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2022-11-12 |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2022-11-12 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b J NEUROL : 2021 |d 2022-11-12 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-12 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2022-11-12 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-12 |
| 920 | 1 | _ | |0 I:(DE-2719)5000055 |k AG Berg |l Parkinson's Disease Genetics AG Berg |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)1210000 |k AG Gasser 1 |l Parkinson Genetics |x 1 |
| 920 | 1 | _ | |0 I:(DE-2719)1240005 |k Core ICRU |l Core ICRU |x 2 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-2719)5000055 |
| 980 | _ | _ | |a I:(DE-2719)1210000 |
| 980 | _ | _ | |a I:(DE-2719)1240005 |
| 980 | 1 | _ | |a FullTexts |
| 999 | C | 5 | |a 10.1007/s00415-018-8800-4 |9 -- missing cx lookup -- |1 R Monastero |p 1050 - |2 Crossref |u Monastero R, Cicero CE, Baschi R, Davì M, Luca A, Restivo V et al (2018) Mild cognitive impairment in Parkinson’s disease. The Parkinson’s disease cognitive study (PACOS). J Neurol 265:1050–1058. https://doi.org/10.1007/s00415-018-8800-4 |t J Neurol |v 265 |y 2018 |
| 999 | C | 5 | |a 10.1159/000478849 |9 -- missing cx lookup -- |1 D Wiesli |p 297 - |2 Crossref |u Wiesli D, Meyer A, Fuhr P, Gschwandtner U (2017) Influence of Mild cognitive impairment, depression, and anxiety on the quality of life of patients with Parkinson disease. Dement Geriatr Cogn Dis Extra 7:297–308. https://doi.org/10.1159/000478849 |t Dement Geriatr Cogn Dis Extra |v 7 |y 2017 |
| 999 | C | 5 | |a 10.1016/j.parkreldis.2014.02.030 |9 -- missing cx lookup -- |1 LML de Lau |p 613 - |2 Crossref |u de Lau LML, Verbaan D, Marinus J, van Hilten JJ (2014) Survival in Parkinson’s disease. Relation with motor and non-motor features. Parkinsonism Relat Disord 20:613–616. https://doi.org/10.1016/j.parkreldis.2014.02.030 |t Parkinsonism Relat Disord |v 20 |y 2014 |
| 999 | C | 5 | |a 10.1002/14651858.CD006504.pub2 |1 M Rolinski |9 -- missing cx lookup -- |2 Crossref |u Rolinski M, Fox C, Maidment I, McShane R (2012) Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson’s disease dementia and cognitive impairment in Parkinson’s disease. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD006504.pub2 |t Cochrane Database Syst Rev |y 2012 |
| 999 | C | 5 | |a 10.1002/14651858.CD003154.pub6 |9 -- missing cx lookup -- |1 R McShane |p CD003154 - |2 Crossref |u McShane R, Westby MJ, Roberts E, Minakaran N, Schneider L, Farrimond LE et al (2019) Memantine for dementia. Cochrane Database Syst Rev 3:CD003154. https://doi.org/10.1002/14651858.CD003154.pub6 |t Cochrane Database Syst Rev |v 3 |y 2019 |
| 999 | C | 5 | |a 10.1212/WNL.0000000000002145 |9 -- missing cx lookup -- |1 IHK Leung |p 1843 - |2 Crossref |u Leung IHK, Walton CC, Hallock H, Lewis SJG, Valenzuela M, Lampit A (2015) Cognitive training in Parkinson disease. A systematic review and meta-analysis. Neurology 85:1843–1851. https://doi.org/10.1212/WNL.0000000000002145 |t Neurology |v 85 |y 2015 |
| 999 | C | 5 | |a 10.1177/1545968317712468 |9 -- missing cx lookup -- |1 BJ Lawrence |p 597 - |2 Crossref |u Lawrence BJ, Gasson N, Bucks RS, Troeung L, Loftus AM (2017) Cognitive training and noninvasive brain stimulation for cognition in Parkinson’s disease: a meta-analysis. Neurorehabil Neural Repair 31:597–608. https://doi.org/10.1177/1545968317712468 |t Neurorehabil Neural Repair |v 31 |y 2017 |
| 999 | C | 5 | |a 10.1007/s00702-019-02113-w |9 -- missing cx lookup -- |1 M Pupíková |p 799 - |2 Crossref |u Pupíková M, Rektorová I (2020) Non-pharmacological management of cognitive impairment in Parkinson’s disease. J Neural Transm 127:799–820. https://doi.org/10.1007/s00702-019-02113-w |t J Neural Transm |v 127 |y 2020 |
| 999 | C | 5 | |a 10.1002/14651858.CD011961.pub2 |1 V Orgeta |9 -- missing cx lookup -- |2 Crossref |u Orgeta V, McDonald KR, Poliakoff E, Hindle JV, Clare L, Leroi I (2020) Cognitive training interventions for dementia and mild cognitive impairment in Parkinson’s disease. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD011961.pub2 |t Cochrane Database Syst Rev |y 2020 |
| 999 | C | 5 | |a 10.1212/WNL.0b013e3182a823ba |9 -- missing cx lookup -- |1 JD Edwards |p 1284 - |2 Crossref |u Edwards JD, Hauser RA, O’Connor ML, Valdés EG, Zesiewicz TA, Uc EY (2013) Randomized trial of cognitive speed of processing training in Parkinson disease. Neurology 81:1284–1290. https://doi.org/10.1212/WNL.0b013e3182a823ba |t Neurology |v 81 |y 2013 |
| 999 | C | 5 | |a 10.1080/09602011.2018.1489860 |9 -- missing cx lookup -- |1 D Fellman |p 673 - |2 Crossref |u Fellman D, Salmi J, Ritakallio L, Ellfolk U, Rinne JO, Laine M (2020) Training working memory updating in Parkinson’s disease. A randomised controlled trial. Neuropsychol Rehabil 30:673–708. https://doi.org/10.1080/09602011.2018.1489860 |t Neuropsychol Rehabil |v 30 |y 2020 |
| 999 | C | 5 | |a 10.1212/WNL.0000000000000287 |9 -- missing cx lookup -- |1 R Zimmermann |p 1219 - |2 Crossref |u Zimmermann R, Gschwandtner U, Benz N, Hatz F, Schindler C, Taub E et al (2014) Cognitive training in Parkinson disease. Cognition-specific vs nonspecific computer training. Neurology 82:1219–1226. https://doi.org/10.1212/WNL.0000000000000287 |t Neurology |v 82 |y 2014 |
| 999 | C | 5 | |a 10.1002/mds.23688 |9 -- missing cx lookup -- |1 AP París |p 1251 - |2 Crossref |u París AP, Saleta HG, de La Cruz Crespo Maraver M, Silvestre E, Freixa MG, Torrellas CP et al (2011) Blind randomized controlled study of the efficacy of cognitive training in Parkinson’s disease. Mov Disord 26:1251–1258. https://doi.org/10.1002/mds.23688 |t Mov Disord |v 26 |y 2011 |
| 999 | C | 5 | |a 10.1177/1545968320981956 |9 -- missing cx lookup -- |1 A Ophey |p 117 - |2 Crossref |u Ophey A, Rehberg S, Giehl K, Eggers C, Reker P, van Eimeren T et al (2021) Predicting working memory training responsiveness in Parkinson’s disease: both “System Hardware” and room for improvement are needed. Neurorehabil Neural Repair 35:117–130. https://doi.org/10.1177/1545968320981956 |t Neurorehabil Neural Repair |v 35 |y 2021 |
| 999 | C | 5 | |a 10.1155/2020/4068706 |9 -- missing cx lookup -- |1 E Kalbe |p 1 - |2 Crossref |u Kalbe E, Folkerts A-K, Ophey A, Eggers C, Elben S, Dimenshteyn K et al (2020) Enhancement of executive functions but not memory by multidomain group cognitive training in patients with Parkinson’s disease and mild cognitive impairment: a multicenter randomized controlled trial. Parkinson’s Disease 2020:1–15. https://doi.org/10.1155/2020/4068706 |t Parkinson’s Disease |v 2020 |y 2020 |
| 999 | C | 5 | |a 10.1136/jnnp.55.3.181 |9 -- missing cx lookup -- |1 AJ Hughes |p 181 - |2 Crossref |u Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatr 55:181–184. https://doi.org/10.1136/jnnp.55.3.181 |t J Neurol Neurosurg Psychiatr |v 55 |y 1992 |
| 999 | C | 5 | |a 10.1002/mds.24893 |9 -- missing cx lookup -- |1 I Litvan |p 349 - |2 Crossref |u Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC et al (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: movement disorder society task force guidelines. Mov Disord 27:349–356. https://doi.org/10.1002/mds.24893 |t Mov Disord |v 27 |y 2012 |
| 999 | C | 5 | |a 10.1016/j.jalz.2012.09.017 |9 -- missing cx lookup -- |1 F Jessen |p 76 - |2 Crossref |u Jessen F, Wolfsgruber S, Wiese B, Bickel H, Mösch E, Kaduszkiewicz H et al (2014) AD dementia risk in late MCI, in early MCI, and in subjective memory impairment. Alzheimer’s Dementia 10:76–83. https://doi.org/10.1016/j.jalz.2012.09.017 |t Alzheimer’s Dementia |v 10 |y 2014 |
| 999 | C | 5 | |a 10.1111/j.1532-5415.2005.53221.x |9 -- missing cx lookup -- |1 ZS Nasreddine |p 695 - |2 Crossref |u Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I et al (2005) The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.x |t J Am Geriatr Soc |v 53 |y 2005 |
| 999 | C | 5 | |a 10.1002/mds.21507 |9 -- missing cx lookup -- |1 M Emre |p 1689 - |2 Crossref |u Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22:1689–1707. https://doi.org/10.1002/mds.21507 |t Mov Disord |v 22 |y 2007 |
| 999 | C | 5 | |a 10.1002/mds.21844 |9 -- missing cx lookup -- |1 B Dubois |p 2314 - |2 Crossref |u Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA et al (2007) Diagnostic procedures for Parkinson’s disease dementia: recommendations from the movement disorder society task force. Mov Disord 22:2314–2324. https://doi.org/10.1002/mds.21844 |t Mov Disord |v 22 |y 2007 |
| 999 | C | 5 | |1 AT Beck |y 1996 |2 Crossref |u Beck AT, Steer RA, Brown GK (1996) Manual for the Beck depression inventory-II. Psychological Corporation, San Antonio, TX, USA |t Manual for the Beck depression inventory-II |
| 999 | C | 5 | |1 G Baller |y 2009 |2 Crossref |u Baller G, Kalbe E, Kaesberg S, Kessler J (2009) Neurovitalis: ein neuropsychologisches Gruppenprogramm zur Förderung der geistigen Leistungsfähigkeit. ProLog, Cologne, Germany |t Neurovitalis. ein neuropsychologisches Gruppenprogramm zur Förderung der geistigen Leistungsfähigkeit |
| 999 | C | 5 | |1 G Baller |y 2021 |2 Crossref |u Baller G, Folkerts AK, Kessler J, Kalbe E (2021) NEUROvitalis Parkinson: ein wissenschaftlich fundiertes Gruppenprogramm zur Förderung der geistigen Leistungsfähigkeit bei Morbus Parkinson Patienten. ProLog, Cologne, Germany |t NEUROvitalis Parkinson: ein wissenschaftlich fundiertes Gruppenprogramm zur Förderung der geistigen Leistungsfähigkeit bei Morbus Parkinson Patienten |
| 999 | C | 5 | |1 H Niemann |y 2008 |2 Crossref |u Niemann H, Sturm W, Thöne-Otto A, Willmes K (2008) CVLT. California Verbal Learning Test. Deutsche Adaptation. Pearson, Frankfurt am Main |t CVLT. California Verbal Learning Test. Deutsche Adaptation |
| 999 | C | 5 | |1 E Strauss |y 2006 |2 Crossref |u Strauss E, Sherman EMS, Spreen O (2006) Compendium of neuropsychological tests: administration, norms and commentary. Oxford University Press, New York, NY |t Compendium of neuropsychological tests: administration, norms and commentary |
| 999 | C | 5 | |1 S Aschenbrenner |y 2000 |2 Crossref |u Aschenbrenner S, Tucha O, Lange KW (2000) Regensburger Wortflüssigkeits-Test: RWT. Hogrefe, Göttingen |t Regensburger Wortflüssigkeits-Test: RWT |
| 999 | C | 5 | |1 DJ Schretlen |y 2011 |2 Crossref |u Schretlen DJ (2011) M-WCST, Modified Wisconsin Card Sorting Test. Psychological Assessment Resources, Lutz, FL |t M-WCST, Modified Wisconsin Card Sorting Test |
| 999 | C | 5 | |1 BA Wilson |y 1991 |2 Crossref |u Wilson BA, Emslie H, Evans JJ, Alderman N, Burgess PW (1991) Behavioural Assessment of the Dysexecutive Syndrome (BADS). Pearson, London |t Behavioural Assessment of the Dysexecutive Syndrome (BADS) |
| 999 | C | 5 | |1 R Brickenkamp |y 2010 |2 Crossref |u Brickenkamp R, Schmidt-Atzert L, Liepmann D (2010) Test d2—Revision. Aufmerksamkeits- und Konzentrationstest. Hogrefe, Göttingen |t Test d2—revision. Aufmerksamkeits- und konzentrationstest |
| 999 | C | 5 | |1 D Wechsler |y 1997 |2 Crossref |u Wechsler D (1997) Wechsler adult intelligence scale—third edition (WAIS-III). Pearson, London |t Wechsler adult intelligence scale—third edition (WAIS-III) |
| 999 | C | 5 | |1 AL Benton |y 1983 |2 Crossref |u Benton AL, Sivan AB, Hamsher K, Varney NR, Spreen O (1983) Benton judgement of line orientation. Psychological Assessment Resources, Lutz, FL |t Benton judgement of line orientation |
| 999 | C | 5 | |a 10.1212/wnl.39.9.1159 |9 -- missing cx lookup -- |1 JC Morris |p 1159 - |2 Crossref |u Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G et al (1989) The consortium to establish a registry for Alzheimer’s disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology 39:1159–1165. https://doi.org/10.1212/wnl.39.9.1159 |t Neurology |v 39 |y 1989 |
| 999 | C | 5 | |1 E Kalbe |y 2010 |2 Crossref |u Kalbe E, Reinhold N, Ender U, Kessler J (2010) ACL—Aphasie-Check-Liste. ProLog, Cologne |t ACL—Aphasie-Check-Liste |
| 999 | C | 5 | |1 H Erzigkeit |y 2010 |2 Crossref |u Erzigkeit H, Lehfeld H (2010) Bayer ADL-Skala. Eine Skala zur Erfassung von Beeinträchtigungen der Alltagskompetenz bei älteren Patienten mit Einbußen der kognitiven Leistungsfähigkeit. Pearson, Frankfurt am Main |t Bayer ADL-Skala. Eine Skala zur Erfassung von Beeinträchtigungen der Alltagskompetenz bei älteren Patienten mit Einbußen der kognitiven Leistungsfähigkeit |
| 999 | C | 5 | |a 10.1016/0895-4356(93)90053-4 |9 -- missing cx lookup -- |1 RA Washburn |p 153 - |2 Crossref |u Washburn RA, Smith KW, Jette AM, Janney CA (1993) The physical activity scale for the elderly (PASE): development and evaluation. J Clin Epidemiol 46:153–162. https://doi.org/10.1016/0895-4356(93)90053-4 |t J Clin Epidemiol |v 46 |y 1993 |
| 999 | C | 5 | |a 10.1093/ageing/26.5.353 |9 -- missing cx lookup -- |1 C Jenkinson |p 353 - |2 Crossref |u Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N (1997) The Parkinson’s disease questionnaire (PDQ-39). Development and validation of a Parkinson’s disease summary index score. Age Ageing 26:353–357. https://doi.org/10.1093/ageing/26.5.353 |t Age Ageing |v 26 |y 1997 |
| 999 | C | 5 | |1 P Zimmermann |y 1991 |2 Crossref |u Zimmermann P, Merser C, Poser U, Sedelmeier P (1991) Ein Fragebogen erlebter Defizite der Aufmerksamkeit (FEDA). University Institute of Psychology, Freiburg |t Ein Fragebogen erlebter Defizite der Aufmerksamkeit (FEDA) |
| 999 | C | 5 | |1 Fahn S, Elton RL, Members of the UPDRS development committee |y 1987 |2 Crossref |u Fahn S, Elton RL, Members of the UPDRS development committee (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Calne DB et al (eds) Recent developments in Parkinson’s disease, vol 2. Macmillan Health Care Information. Florham Park, NJ, pp 153–164 |t Recent developments in Parkinson’s disease |
| 999 | C | 5 | |a 10.1016/s1353-8020(99)00062-0 |9 -- missing cx lookup -- |1 N Giladi |p 165 - |2 Crossref |u Giladi N, Shabtai H, Simon ES, Biran S, Tal J, Korczyn AD (2000) Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat Disord 6:165–170. https://doi.org/10.1016/s1353-8020(99)00062-0 |t Parkinsonism Relat Disord |v 6 |y 2000 |
| 999 | C | 5 | |1 J Cohen |y 1977 |2 Crossref |u Cohen J (1977) Statistical power analysis for the behavioral sciences. Academic Press, New York, NY |t Statistical power analysis for the behavioral sciences |
| 999 | C | 5 | |a 10.1093/geronb/gbn026 |9 -- missing cx lookup -- |1 JBS Langbaum |p 14 - |2 Crossref |u Langbaum JBS, Rebok GW, Bandeen-Roche K, Carlson MC (2009) Predicting memory training response patterns: results from ACTIVE. J Gerontol B Psychol Sci Soc Sci 64:14–23. https://doi.org/10.1093/geronb/gbn026 |t J Gerontol B Psychol Sci Soc Sci |v 64 |y 2009 |
| 999 | C | 5 | |a 10.1080/09602010903343012 |9 -- missing cx lookup -- |1 L Jean |p 377 - |2 Crossref |u Jean L, Simard M, Wiederkehr S, Bergeron M-E, Turgeon Y, Hudon C et al (2010) Efficacy of a cognitive training programme for mild cognitive impairment: results of a randomised controlled study. Neuropsychol Rehabil 20:377–405. https://doi.org/10.1080/09602010903343012 |t Neuropsychol Rehabil |v 20 |y 2010 |
| 999 | C | 5 | |a 10.1016/j.chb.2012.01.012 |9 -- missing cx lookup -- |1 LA Whitlock |p 1091 - |2 Crossref |u Whitlock LA, McLaughlin AC, Allaire JC (2012) Individual differences in response to cognitive training: using a multi-modal, attentionally demanding game-based intervention for older adults. Comput Hum Behav 28:1091–1096. https://doi.org/10.1016/j.chb.2012.01.012 |t Comput Hum Behav |v 28 |y 2012 |
| 999 | C | 5 | |a 10.1017/S1041610212002049 |9 -- missing cx lookup -- |1 JK Fairchild |p 607 - |2 Crossref |u Fairchild JK, Friedman L, Rosen AC, Yesavage JA (2013) Which older adults maintain benefit from cognitive training? Use of signal detection methods to identify long-term treatment gains. Int Psychogeriatr 25:607–616. https://doi.org/10.1017/S1041610212002049 |t Int Psychogeriatr |v 25 |y 2013 |
| 999 | C | 5 | |a 10.1177/0898264312461937 |9 -- missing cx lookup -- |1 GW Rebok |p 21S - |2 Crossref |u Rebok GW, Langbaum JBS, Jones RN, Gross AL, Parisi JM, Spira AP et al (2013) Memory training in the ACTIVE study: how much is needed and who benefits? J Aging Health 25:21S-42S. https://doi.org/10.1177/0898264312461937 |t J Aging Health |v 25 |y 2013 |
| 999 | C | 5 | |a 10.3389/fnagi.2015.00187 |9 -- missing cx lookup -- |1 J Rahe |p 187 - |2 Crossref |u Rahe J, Becker J, Fink GR, Kessler J, Kukolja J, Rahn A et al (2015) Cognitive training with and without additional physical activity in healthy older adults: cognitive effects, neurobiological mechanisms, and prediction of training success. Front Aging Neurosci 7:187. https://doi.org/10.3389/fnagi.2015.00187 |t Front Aging Neurosci |v 7 |y 2015 |
| 999 | C | 5 | |a 10.1002/brb3.1861 |9 -- missing cx lookup -- |1 M Roheger |p e01861 - |2 Crossref |u Roheger M, Kalbe E, Corbett A, Brooker H, Ballard C (2020) Predictors of changes after reasoning training in healthy adults. Brain Behav 10:e01861. https://doi.org/10.1002/brb3.1861 |t Brain Behav |v 10 |y 2020 |
| 999 | C | 5 | |a 10.1080/13825585.2019.1617396 |9 -- missing cx lookup -- |1 M Roheger |p 351 - |2 Crossref |u Roheger M, Meyer J, Kessler J, Kalbe E (2020) Predicting short- and long-term cognitive training success in healthy older adults: who benefits? Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 27:351–369. https://doi.org/10.1080/13825585.2019.1617396 |t Neuropsychol Dev Cogn B Aging Neuropsychol Cogn |v 27 |y 2020 |
| 999 | C | 5 | |a 10.1136/jnnp-2016-313838 |9 -- missing cx lookup -- |1 E Kalbe |p 1099 - |2 Crossref |u Kalbe E, Rehberg SP, Heber I, Kronenbuerger M, Schulz JB, Storch A et al (2016) Subtypes of mild cognitive impairment in patients with Parkinson’s disease: evidence from the LANDSCAPE study. J Neurol Neurosurg Psychiatry 87:1099–1105. https://doi.org/10.1136/jnnp-2016-313838 |t J Neurol Neurosurg Psychiatry |v 87 |y 2016 |
| 999 | C | 5 | |a 10.1212/WNL.0000000000001043 |9 -- missing cx lookup -- |1 J Peña |p 2167 - |2 Crossref |u Peña J, Ibarretxe-Bilbao N, García-Gorostiaga I, Gomez-Beldarrain MA, Díez-Cirarda M, Ojeda N (2014) Improving functional disability and cognition in Parkinson disease: randomized controlled trial. Neurology 83:2167–2174. https://doi.org/10.1212/WNL.0000000000001043 |t Neurology |v 83 |y 2014 |
| 999 | C | 5 | |a 10.1016/j.parkreldis.2014.08.023 |9 -- missing cx lookup -- |1 A Petrelli |p 1196 - |2 Crossref |u Petrelli A, Kaesberg S, Barbe MT, Timmermann L, Fink GR, Kessler J et al (2014) Effects of cognitive training in Parkinson’s disease: a randomized controlled trial. Parkinsonism Relat Disord 20:1196–1202. https://doi.org/10.1016/j.parkreldis.2014.08.023 |t Parkinsonism Relat Disord |v 20 |y 2014 |
| 999 | C | 5 | |a 10.1016/j.ijmedinf.2018.04.005 |9 -- missing cx lookup -- |1 A Alloni |p 64 - |2 Crossref |u Alloni A, Quaglini S, Panzarasa S, Sinforiani E, Bernini S (2018) Evaluation of an ontology-based system for computerized cognitive rehabilitation. Int J Med Inform 115:64–72. https://doi.org/10.1016/j.ijmedinf.2018.04.005 |t Int J Med Inform |v 115 |y 2018 |
| 999 | C | 5 | |a 10.1155/2018/4318475 |9 -- missing cx lookup -- |1 BJ Lawrence |p 4318475 - |2 Crossref |u Lawrence BJ, Gasson N, Johnson AR, Booth L, Loftus AM (2018) Cognitive training and transcranial direct current stimulation for mild cognitive impairment in Parkinson’s disease: a randomized controlled trial. Parkinson’s Disease 2018:4318475. https://doi.org/10.1155/2018/4318475 |t Parkinson’s Disease |v 2018 |y 2018 |
| 999 | C | 5 | |a 10.1016/S0278-2626(03)00180-5 |9 -- missing cx lookup -- |1 CI Higginson |p 343 - |2 Crossref |u Higginson CI, King DS, Levine D, Wheelock VL, Khamphay NO, Sigvardt KA (2003) The relationship between executive function and verbal memory in Parkinson’s disease. Brain Cogn 52:343–352. https://doi.org/10.1016/S0278-2626(03)00180-5 |t Brain Cogn |v 52 |y 2003 |
| 999 | C | 5 | |a 10.1093/arclin/acp029 |9 -- missing cx lookup -- |1 TJ O’Brien |p 237 - |2 Crossref |u O’Brien TJ, Wadley V, Nicholas AP, Stover NP, Watts R, Griffith HR (2009) The contribution of executive control on verbal-learning impairment in patients with Parkinson’s disease with dementia and Alzheimer’s disease. Arch Clin Neuropsychol 24:237–244. https://doi.org/10.1093/arclin/acp029 |t Arch Clin Neuropsychol |v 24 |y 2009 |
| 999 | C | 5 | |a 10.1080/09084282.2011.643960 |9 -- missing cx lookup -- |1 BD Hill |p 198 - |2 Crossref |u Hill BD, Alosco M, Bauer L, Tremont G (2012) The relation of executive functioning to CVLT-II learning, memory, and process indexes. Appl Neuropsychol Adult 19:198–206. https://doi.org/10.1080/09084282.2011.643960 |t Appl Neuropsychol Adult |v 19 |y 2012 |
| 999 | C | 5 | |a 10.1080/13854040590947461 |9 -- missing cx lookup -- |1 BL Brooks |p 230 - |2 Crossref |u Brooks BL, Weaver LE, Scialfa CT (2006) Does impaired executive functioning differentially impact verbal memory measures in older adults with suspected dementia? Clin Neuropsychol 20:230–242. https://doi.org/10.1080/13854040590947461 |t Clin Neuropsychol |v 20 |y 2006 |
| 999 | C | 5 | |a 10.1093/brain/awg128 |9 -- missing cx lookup -- |1 MP Alexander |p 1493 - |2 Crossref |u Alexander MP, Stuss DT, Fansabedian N (2003) California Verbal Learning Test: performance by patients with focal frontal and non-frontal lesions. Brain 126:1493–1503. https://doi.org/10.1093/brain/awg128 |t Brain |v 126 |y 2003 |
| 999 | C | 5 | |a 10.1080/01688639308402554 |9 -- missing cx lookup -- |1 JS Janowsky |p 159 - |2 Crossref |u Janowsky JS, Thomas-Thrapp LJ (1993) Complex figure recall in the elderly: a deficit in memory or constructional strategy? J Clin Exp Neuropsychol 15:159–169. https://doi.org/10.1080/01688639308402554 |t J Clin Exp Neuropsychol |v 15 |y 1993 |
| 999 | C | 5 | |a 10.1016/S0887-6177(00)80060-8 |9 -- missing cx lookup -- |1 H Westervelt |p 684 - |2 Crossref |u Westervelt H (2000) The impact of organizational strategy on recall of the Rey-Osterrieth complex figure. Arch Clin Neuropsychol 15:684. https://doi.org/10.1016/S0887-6177(00)80060-8 |t Arch Clin Neuropsychol |v 15 |y 2000 |
| 999 | C | 5 | |a 10.1177/1533317514539542 |9 -- missing cx lookup -- |1 V Moro |p 153 - |2 Crossref |u Moro V, Condoleo MT, Valbusa V, Broggio E, Moretto G, Gambina G (2015) Cognitive stimulation of executive functions in mild cognitive impairment: specific efficacy and impact in memory. Am J Alzheimers Dis Other Demen 30:153–164. https://doi.org/10.1177/1533317514539542 |t Am J Alzheimers Dis Other Demen |v 30 |y 2015 |
| 999 | C | 5 | |a 10.1016/S0140-6736(96)90410-9 |9 -- missing cx lookup -- |1 PL Yudkin |p 241 - |2 Crossref |u Yudkin PL, Stratton IM (1996) How to deal with regression to the mean in intervention studies. The Lancet 347:241–243. https://doi.org/10.1016/S0140-6736(96)90410-9 |t The Lancet |v 347 |y 1996 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|
guest ::